First Ascent Biomedical
Cancer treatment as individual as your fingerprint
- Headquarters
- Beaverton, Oregon
- Founded
- 2021
- Business Model
- B2B
- Website
- firstascentbio.com
- Total Funding
- $7.7M
- Last Round
- $1.7M GrantMar 2025
About
First Ascent Biomedical provides AI-driven precision medicine for cancer treatment. Their proprietary live-cell platform tests multiple FDA-approved therapies in parallel on patient tumors to deliver personalized treatment recommendations within 10 days.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account